Authored By: Sarah
11 Jul 2024

 Continuous Positive Airway Pressure (CPAP) Market in US Size to grow by USD 428.84 million between 2024-2028

According to a research report “ Continuous Positive Airway Pressure (CPAP) Market in US” by Product (Devices, Accessories, Masks) Distribution Channel (Offline, Online) Revenue Stream (Cash pay, Insurance) Geography (North America)- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 428.84 million, at a CAGR of  6.42% during the forecast period. The US market for Continuous Positive Airway Pressure (CPAP) devices is experiencing significant growth due to the increasing prevalence of sleep disorders, particularly obstructive sleep apnea (OSA). According to the Centers for Disease Control and Prevention (CDC), insomnia, narcolepsy, restless leg syndrome (RLS), and sleep apnea are among the major sleep disorders affecting the population. OSA, a chronic condition characterized by the upper airway closing during sleep, is linked to an aging population, changing lifestyles, and the rise of chronic diseases. CPAP devices are an effective treatment for OSA, making them a crucial solution for improving sleep quality and overall health in the US.

Browse market data tables, figures, and in-depth TOC on “Continuous Positive Airway Pressure (CPAP) Market in US” by Product (Devices, Accessories, Masks) Distribution Channel (Offline, Online) Revenue Stream (Cash pay, Insurance) Geography (North America) Global Forecast to 2028. Download Free Sample


By Product, the Devices segment is projected to dominate the market size in 2024

In the US CPAP market, the offline segment, comprised of specialty stores and company outlets, remains a significant distribution channel. Consumers often prefer this channel for purchasing CPAP devices and accessories due to the ability to physically examine products before purchase and take advantage of discounts and enhanced shopping experiences. Vendors in this segment leverage factors such as efficient logistics, strategic locations, streamlined production processes, and effective inventory management to competitively price a wide range of medical devices, thereby bolstering the offline segment's growth in the US CPAP market during the forecast period.

By Distribution Channel, Offline  segment is expected to hold the largest market size for the year 2024

The CPAP market in the US is experiencing significant growth, driven by the expanding pool of undiagnosed sleep apnea patients and increasing awareness of the detrimental effects of untreated obstructive sleep apnea (OSA). The convenience and comfort of home sleep apnea tests (HSATs) have led to a rise in their utilization. Advanced technologies, such as artificial intelligence (AI), are revolutionizing sleep apnea devices, creating new opportunities for the market. Government initiatives to make OSA treatment more affordable and favorable healthcare policies further fuel market expansion during the forecast period.

North America is forecasted to hold the largest market size by region in 2024


The Continuous Positive Airway Pressure (CPAP) Market in US growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Compumedics Ltd.
  • DeVilbiss Healthcare GmbH
  • Dragerwerk AG and Co. KGaA
  • Ess Pee Enterprises
  • Fisher and Paykel Healthcare Corp. Ltd.
  • Hamilton Bonaduz AG
  • Koninklijke Philips N.V.
  • Manish Enterprises
  • Medical Depot Inc.
  • Medtronic Plc
  • Narang Medical Ltd.
  • NXP Semiconductors NV
  • React Health
  • ResMed Inc.
  • Sleepnet Corp.
  • Smiths Group Plc
  • TG Eakin Ltd.
  • Wellell Inc.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Continuous Positive Airway Pressure (CPAP) market in the US is witnessing significant growth due to the rising prevalence of sleep disorders, particularly sleep apnea and snoring. According to the American Sleep Association, an estimated 22 million Americans suffer from sleep apnea, a condition that causes repeated interruptions in breathing during sleep, leading to symptoms like runny nose, claustrophobic feeling, and daytime drowsiness. Technological advances in CPAP devices, such as mask designs, miniaturization, and integration with telehealth and telemedicine, have made home-based treatment more accessible and convenient. However, challenges like side effects, undersupply, and insurance coverages continue to impact the market. The COVID-19 virus has further highlighted the importance of home-based treatment as hospitals face ventilator shortages. The geriatric population, with its high prevalence of comorbidities and sleep disorders, is a significant market driver. The economic burden of untreated sleep apnea is estimated to be USD65 billion in the US alone. Key players like Mayo Clinic, ResMed, and the American Academy of Sleep Medicine are leading the charge in disease management and technological advances in CPAP devices. The growing disposable income and increasing awareness of technologically advanced devices are also fueling market growth. Global obesity prevalence is another factor contributing to the rising demand for CPAP devices. Despite these opportunities, ensuring compliance rate remains a challenge, with an estimated 50% of patients discontinuing use within the first year.

Market Research Overview

The Continuous Positive Airway Pressure (CPAP) market in the US is witnessing significant growth due to the increasing prevalence of sleep disorders, particularly obstructive sleep apnea (OSA), and the growing awareness and acceptance of CPAP therapy. The market is characterized by a competitive pricing structure, with international players like Fosun Pharma, BMC Medical, Teijin Pharma, and Cardinal Health competing with established players such as Invacare Corporation, Smiths Medical, Armstrong Medical Inc, Medtronic, and Koninklijke Philips. According to a recent FMI study, the US CPAP market is expected to grow at a steady CAGR due to the reliability and effectiveness of these devices in treating sleep disorders. Novel innovations in respiratory assistance devices, such as mask designs, technological advances, telehealth, telemedicine, and connected devices, are also driving market growth. However, the high expense price point of CPAP devices and patient compliance issues, such as aerosol generation, contamination, nasal congestion, runny nose, and claustrophobic feeling, are some of the challenges faced by the market. The coronavirus crisis has further highlighted the need for home-based CPAP therapy and the potential undersupply of ventilators. Key players in the market are focusing on disease management, snoring, and insurances coverages to increase their market share. The geriatric population, comorbidities, global obesity prevalence, and untreated sleep apnea contribute to the economic burden of sleep disorders, making the market an attractive investment opportunity. The American Sleep Association, Mayo Clinic, and American Academy of Sleep Medicine are some of the key organizations driving awareness and research in the field.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!